Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 3
2006 1
2007 9
2008 3
2009 4
2010 5
2011 10
2012 10
2013 13
2014 12
2015 18
2016 14
2017 14
2018 24
2019 34
2020 30
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean qiu yan chen (128 results)?
Future of Radiotherapy in Nasopharyngeal Carcinoma.
Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ. Sun XS, et al. Br J Radiol. 2019 Oct;92(1102):20190209. doi: 10.1259/bjr.20190209. Epub 2019 Jul 9. Br J Radiol. 2019. PMID: 31265322 Free PMC article.
STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion.
Zhang CX, Ye SB, Ni JJ, Cai TT, Liu YN, Huang DJ, Mai HQ, Chen QY, He J, Zhang XS, Zeng YX, Li J, Cui J. Zhang CX, et al. Cell Death Differ. 2019 Nov;26(11):2314-2328. doi: 10.1038/s41418-019-0302-0. Epub 2019 Feb 28. Cell Death Differ. 2019. PMID: 30816302 Free PMC article.
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma.
Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu YM, Li JP, Liu YN, Luo YL, Zhao Y, Zhang Y, Xia TL, Liu SX, Liu Q, Wang GN, You R, Peng JY, Li J, Han F, Wang J, Chen QY, Zhang L, Mai HQ, Gewurz BE, Zhao B, Young LS, Zhong Q, Bai F, Zeng MS. Jin S, et al. Cell Res. 2020 Nov;30(11):950-965. doi: 10.1038/s41422-020-00402-8. Epub 2020 Sep 8. Cell Res. 2020. PMID: 32901110
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
You R, Liu YP, Huang PY, Zou X, Sun R, He YX, Wu YS, Shen GP, Zhang HD, Duan CY, Tan SH, Cao JY, Li JB, Xie YL, Zhang YN, Wang ZQ, Yang Q, Lin M, Jiang R, Zhang MX, Hua YJ, Tang LQ, Zhuang AH, Chen QY, Guo L, Mo HY, Chen Y, Mai HQ, Ling L, Liu Q, Chua MLK, Chen MY. You R, et al. JAMA Oncol. 2020 Sep 1;6(9):1345-1352. doi: 10.1001/jamaoncol.2020.1808. JAMA Oncol. 2020. PMID: 32701129
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY. Yang Q, et al. Eur J Cancer. 2019 Sep;119:87-96. doi: 10.1016/j.ejca.2019.07.007. Epub 2019 Aug 16. Eur J Cancer. 2019. PMID: 31425966 Clinical Trial.
Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma.
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He J, Peng JY, Chen QY, Mo HY, Jun-Cui, Zhang XS, Zeng YX, Li J. Ye SB, et al. J Pathol. 2016 Nov;240(3):329-340. doi: 10.1002/path.4781. J Pathol. 2016. PMID: 27538493
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT, Ye SB, Liu YN, He J, Chen QY, Mai HQ, Zhang CX, Cui J, Zhang XS, Busson P, Zeng YX, Li J. Cai TT, et al. PLoS Pathog. 2017 Jul 21;13(7):e1006503. doi: 10.1371/journal.ppat.1006503. eCollection 2017 Jul. PLoS Pathog. 2017. PMID: 28732079 Free PMC article.
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma.
Liu SL, Bian LJ, Liu ZX, Chen QY, Sun XS, Sun R, Luo DH, Li XY, Xiao BB, Yan JJ, Lu ZJ, Yan SM, Yuan L, Tang LQ, Li JM, Mai HQ. Liu SL, et al. J Immunother Cancer. 2020 Apr;8(1):e000205. doi: 10.1136/jitc-2019-000205. J Immunother Cancer. 2020. PMID: 32303611 Free PMC article.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Tang LQ, et al. Lancet Oncol. 2018 Apr;19(4):461-473. doi: 10.1016/S1470-2045(18)30104-9. Epub 2018 Feb 28. Lancet Oncol. 2018. PMID: 29501366 Clinical Trial.
Structural Basis of Arrestin-Dependent Signal Transduction.
Chen Q, Iverson TM, Gurevich VV. Chen Q, et al. Trends Biochem Sci. 2018 Jun;43(6):412-423. doi: 10.1016/j.tibs.2018.03.005. Epub 2018 Apr 7. Trends Biochem Sci. 2018. PMID: 29636212 Free PMC article. Review.
190 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback